Dr. Syed Rizvi, M.D

NPI: 1801089289
Total Payments
$17,719
2024 Payments
$553.02
Companies
15
Transactions
162
Medicare Patients
839
Medicare Billing
$87,961

Payment Breakdown by Category

Consulting$8,514 (48.0%)
Other$5,698 (32.2%)
Food & Beverage$3,029 (17.1%)
Travel$476.69 (2.7%)
Education$1.79 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $8,514 1 48.0%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $5,698 6 32.2%
Food and Beverage $3,029 151 17.1%
Travel and Lodging $476.69 3 2.7%
Education $1.79 1 0.0%

Top Paying Companies

Company Total Records Latest Year
EMD Serono, Inc. $8,915 8 $0 (2023)
Otsuka America Pharmaceutical, Inc. $6,314 38 $0 (2020)
Stryker Corporation $553.02 8 $0 (2024)
Lundbeck LLC $358.79 26 $0 (2019)
Neurocrine Biosciences, Inc. $351.61 14 $0 (2020)
Alkermes, Inc. $329.48 17 $0 (2020)
Janssen Pharmaceuticals, Inc $284.99 18 $0 (2020)
Teva Pharmaceuticals USA, Inc. $243.70 11 $0 (2019)
Sunovion Pharmaceuticals Inc. $185.98 10 $0 (2020)
Allergan, Inc. $104.79 7 $0 (2020)

Payment History by Year

Year Amount Transactions Top Company
2024 $553.02 8 Stryker Corporation ($553.02)
2023 $8,928 9 EMD Serono, Inc. ($8,915)
2020 $1,278 16 Otsuka America Pharmaceutical, Inc. ($1,121)
2019 $6,114 82 Otsuka America Pharmaceutical, Inc. ($5,139)
2018 $672.99 36 Teva Pharmaceuticals USA, Inc. ($158.38)
2017 $174.02 11 Sunovion Pharmaceuticals Inc. ($65.66)

All Payment Transactions

162 individual payment records from CMS Open Payments — Page 1 of 7

Date Company Product Nature Form Amount Type
07/18/2024 Stryker Corporation ANCHORAGE (Device) Food and Beverage In-kind items and services $155.34 General
Category: TRAUMA & EXTREMETIES
04/20/2024 Stryker Corporation ACTISHIELD (Device) Food and Beverage In-kind items and services $27.61 General
Category: TRAUMA & EXTREMITIES
04/19/2024 Stryker Corporation INFINITY ADAPTIS (Device) Food and Beverage In-kind items and services $83.05 General
Category: TRAUMA & EXTREMITIES
04/19/2024 Stryker Corporation INFINITY ADAPTIS (Device) Food and Beverage In-kind items and services $83.05 General
Category: TRAUMA & EXTREMITIES
04/18/2024 Stryker Corporation INFINITY ADAPTIS (Device) Food and Beverage In-kind items and services $129.34 General
Category: TRAUMA & EXTREMITIES
04/18/2024 Stryker Corporation ALLOMATRIX (Device) Food and Beverage In-kind items and services $44.64 General
Category: BONE SUBSTITUTES
04/18/2024 Stryker Corporation INFINITY ADAPTIS (Device) Food and Beverage In-kind items and services $13.19 General
Category: TRAUMA & EXTREMITIES
01/08/2024 Stryker Corporation ACTISHIELD (Device) Food and Beverage In-kind items and services $16.80 General
Category: TRAUMA & EXTREMITIES
08/24/2023 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $13.12 General
Category: NEUROSCIENCE
08/02/2023 EMD Serono, Inc. Evobrutinib Consulting Fee Cash or cash equivalent $8,513.75 General
06/26/2023 EMD Serono, Inc. Food and Beverage Cash or cash equivalent $54.00 General
06/24/2023 EMD Serono, Inc. Food and Beverage Cash or cash equivalent $61.20 General
06/24/2023 EMD Serono, Inc. Food and Beverage Cash or cash equivalent $27.00 General
06/24/2023 EMD Serono, Inc. Food and Beverage Cash or cash equivalent $27.00 General
06/23/2023 EMD Serono, Inc. Travel and Lodging Cash or cash equivalent $211.05 General
06/23/2023 EMD Serono, Inc. Food and Beverage Cash or cash equivalent $11.65 General
06/23/2023 EMD Serono, Inc. Food and Beverage Cash or cash equivalent $9.00 General
04/22/2020 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $702.00 General
Category: PSYCHIATRY
04/17/2020 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $351.00 General
Category: PSYCHIATRY
03/05/2020 Vanda Pharmaceuticals Inc. HETLIOZ (Drug) Food and Beverage In-kind items and services $15.00 General
Category: NON-24-HOUR SLEEP-WAKE DISORDER
02/25/2020 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug) Food and Beverage In-kind items and services $19.41 General
Category: PSYCHIATRY
02/25/2020 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug) Food and Beverage In-kind items and services $3.02 General
Category: PSYCHIATRY
02/17/2020 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $23.82 General
Category: NEUROLOGY
02/13/2020 Allergan, Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $16.56 General
Category: NEUROSCIENCE
02/06/2020 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $15.88 General
Category: PSYCHIATRY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 139 324 $82,000 $16,978
2022 2 166 382 $98,000 $19,637
2021 1 170 518 $130,145 $28,379
2020 2 364 589 $117,245 $22,966
Total Patients
839
Total Services
1,813
Medicare Billing
$87,961
Procedure Codes
12

All Medicare Procedures & Services

12 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 84 221 $55,250 $11,535 20.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 43 90 $22,500 $4,259 18.9%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2023 12 13 $4,250 $1,184 27.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 106 282 $70,500 $12,874 18.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 35 74 $18,500 $4,311 23.3%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 14 14 $4,875 $1,264 25.9%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 11 12 $4,125 $1,189 28.8%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 153 501 $125,895 $27,084 21.5%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 17 17 $4,250 $1,295 30.5%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 169 382 $89,320 $19,992 22.4%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 111 120 $26,620 $2,203 8.3%
Q3014 Telehealth originating site facility fee Office 2020 84 87 $1,305 $771.12 59.1%

About Dr. Syed Rizvi, M.D

Dr. Syed Rizvi, M.D is a Psychiatry healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/20/2007. The National Provider Identifier (NPI) number assigned to this provider is 1801089289.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Syed Rizvi, M.D has received a total of $17,719 in payments from pharmaceutical and medical device companies, with $553.02 received in 2024. These payments were reported across 162 transactions from 15 companies. The most common payment nature is "Consulting Fee" ($8,514).

As a Medicare-enrolled provider, Rizvi has provided services to 839 Medicare beneficiaries, totaling 1,813 services with total Medicare billing of $87,961. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.

Practice Information

  • Specialty Psychiatry
  • Location Lexington, KY
  • Active Since 08/20/2007
  • Last Updated 05/26/2020
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • NPI Number 1801089289

Products in Payments

  • Evobrutinib $8,514
  • ABILIFY MAINTENA (Drug) $6,439
  • INGREZZA (Drug) $351.61
  • INFINITY ADAPTIS (Device) $308.63
  • INVEGA SUSTENNA (Drug) $268.43
  • AUSTEDO (Drug) $243.70
  • ARISTADA (Drug) $242.78
  • REXULTI (Drug) $233.04
  • LATUDA (Drug) $185.98
  • ANCHORAGE (Device) $155.34
  • VRAYLAR (Drug) $117.91
  • Aristada 441 mg (Drug) $86.70
  • ALLOMATRIX (Device) $44.64
  • ACTISHIELD (Device) $44.41
  • PERSERIS (Drug) $25.02
  • SPRAVATO (Drug) $16.56
  • HETLIOZ (Drug) $15.00
  • NUPLAZID (Drug) $14.19
  • VYVANSE (Drug) $11.42

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in Lexington